InfiXco
The Ideal Solution to Cross-Infection Prevention

The frequency of public area sterilization, normally in an interval of two hours, with normal disinfection products, is simply not enough. While disinfection products are effective immediately (less than 10 minutes,) their performance drops quickly after 20 minutes of being on surface. In the APAC region, there is still a huge room of improvement in terms of improving the virus containment measures. Proper education on good public health and national-level public health strategy and measurement play a significant role in increasing the infection control level.

The Environmental Protection Agency (EPA) has already realized that for fighting with COVID-19 just disinfection won’t be enough, especially for public area and public transportation. To bolster the sterilization measures, anti-microbial coating can act as a supplement to disinfection processes. One company that is playing a pivotal role in this initiative is InfiXco a leading nano science-based company specializing in catalyst, bactericide, optical, high-performance sol and photokinetic materials. The company’s corporate name, InfiXco, means “Infinite” connects with “Core advanced material,” where ‘X’ represents “connection”, and “unknown to explore.” The name illustrates InfiXco’s dedication to developing a core advanced material with excellent performance in order to explore infinite possibilities.

InfiXco has introduced a novel solution, SepticFree™️, an anti-microbial and anti-viral coating that can combat the spread of cross-infection in any space, specifically designed for public places with high risk of cross infection, such as hospitals, subways, schools, where elevator handrails, lift, door handles are frequently touched. A 12-17 months case study in U.S. proved the utilization of SepticFree™️ technology in hospital can reduce URI (Upper respiratory tract infection) infection by more than 70 percent and EENT (eye, ear, nose & throat) infection by more than 50 percent. “Our solution can prevent virus, bacteria, and the transmission of the same, and has proved to effective against all enveloped virus by lab study. So, it covers SARS, SARS-Cov2 (COVID-19), MERS, Flu, RSV, Human Corona virus, to name a few,” notes Rebecca H., Co founder of InfiXco.

Rebecca explains that using good cross infection technology can reduce the R (reproduction number) value of a virus spreading. If original R is 2-3 (like SARS), a technology can reduce 70 percent infection, so that will lead to just 0.2 R value for the disease and it will be controlled.

Our Solution Can Prevent Virus, Bacteria, And The Transmission Of The Same, And Has Proved To Effective Against All Enveloped Virus By Lab Study

But for COVID-19, it seems R value is 10-15 in some cases. Therefore, even after applying 70 percent reducing technology, its R value is still 2-3. In this scenario, traditional sterilization methods are rendered ineffective. Advanced technologies like SepticFree™️ offers a better alternative while enabling companies to save labor cost for public area sterilization and provide stronger protection.
InfiXco’s technology is backed by the expertise of an international advanced material R&D team. Rebecca adds, “Our business partners range from Europe to America. Every product and solution we develop is based on our deep understanding of customers. We do not have interest in pursuing short-term benefits. Instead, we advocate a sustainable and eco development. We are pleased with the changes that our advanced material technology applied to make benefits to the whole society.”

The next-gen solution has passed the strict oral toxic free test and skin irritation test with the highest level, certified by SGS. While prevention of virus though vaccination can be a revolution to public health, SepticFree™and all relative technology might as well prove to be the second revolution. InfiXco is also narrowing down its focus on some specific industries or fields to offer customized SepticFree™️ solution. For instance, the company is aiming to expand to the pet care field to ensure pets get good protection against virus and bacteria. For the and frequent touch point protection field, new technology will help reduce cross infection in public area reduce the spreading of pandemics. “We believe our new technology can reduce disease, death, and bring immense huge value to the human society,” ends Rebecca.